nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Topotecan—lung cancer	0.0427	0.142	CbGbCtD
Paricalcitol—CYP3A4—Gefitinib—lung cancer	0.0391	0.13	CbGbCtD
Paricalcitol—CYP3A4—Teniposide—lung cancer	0.0379	0.126	CbGbCtD
Paricalcitol—CYP3A4—Vinorelbine—lung cancer	0.0301	0.1	CbGbCtD
Paricalcitol—CYP3A4—Crizotinib—lung cancer	0.0239	0.0796	CbGbCtD
Paricalcitol—CYP3A4—Erlotinib—lung cancer	0.0231	0.0768	CbGbCtD
Paricalcitol—CYP3A4—Paclitaxel—lung cancer	0.0211	0.0703	CbGbCtD
Paricalcitol—CYP3A4—Irinotecan—lung cancer	0.0209	0.0694	CbGbCtD
Paricalcitol—CYP3A4—Vinblastine—lung cancer	0.0185	0.0617	CbGbCtD
Paricalcitol—CYP3A4—Etoposide—lung cancer	0.0167	0.0556	CbGbCtD
Paricalcitol—CYP3A4—Docetaxel—lung cancer	0.0153	0.0508	CbGbCtD
Paricalcitol—CYP3A4—Doxorubicin—lung cancer	0.0114	0.0379	CbGbCtD
Paricalcitol—UGT1A4—respiratory system—lung cancer	0.0069	0.151	CbGeAlD
Paricalcitol—VDR—mammary gland—lung cancer	0.0057	0.125	CbGeAlD
Paricalcitol—CYP24A1—bronchus—lung cancer	0.00567	0.125	CbGeAlD
Paricalcitol—CYP24A1—trachea—lung cancer	0.0051	0.112	CbGeAlD
Paricalcitol—VDR—respiratory system—lung cancer	0.0038	0.0834	CbGeAlD
Paricalcitol—CYP24A1—lung—lung cancer	0.00366	0.0804	CbGeAlD
Paricalcitol—VDR—epithelium—lung cancer	0.00317	0.0697	CbGeAlD
Paricalcitol—VDR—bronchus—lung cancer	0.00312	0.0686	CbGeAlD
Paricalcitol—VDR—trachea—lung cancer	0.00281	0.0616	CbGeAlD
Paricalcitol—VDR—bone marrow—lung cancer	0.00223	0.0489	CbGeAlD
Paricalcitol—VDR—lung—lung cancer	0.00202	0.0443	CbGeAlD
Paricalcitol—VDR—lymph node—lung cancer	0.00138	0.0303	CbGeAlD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000268	0.00104	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000264	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000264	0.00102	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MMP2—lung cancer	0.000263	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLBD1—lung cancer	0.000256	0.000989	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000253	0.00098	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000253	0.000979	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—KHSRP—lung cancer	0.000252	0.000975	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000252	0.000973	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD17B10—lung cancer	0.000234	0.000904	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MDM2—lung cancer	0.000234	0.000904	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ATP5H—lung cancer	0.000229	0.000887	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—POMC—lung cancer	0.000229	0.000884	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EIF2B5—lung cancer	0.00022	0.000852	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CKB—lung cancer	0.000217	0.000841	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NOTCH3—lung cancer	0.000212	0.000819	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000208	0.000803	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLBD1—lung cancer	0.000204	0.00079	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM2—lung cancer	0.000204	0.00079	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CNDP2—lung cancer	0.000204	0.00079	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—JUN—lung cancer	0.000203	0.000786	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—JUNB—lung cancer	0.000201	0.000776	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DICER1—lung cancer	0.000199	0.00077	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000199	0.00077	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTMR3—lung cancer	0.000199	0.000769	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000198	0.000765	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CDKN1A—lung cancer	0.000197	0.000762	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PTEN—lung cancer	0.000197	0.00076	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PGAM1—lung cancer	0.000194	0.000749	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000189	0.000732	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—EP300—lung cancer	0.000187	0.000725	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD17B10—lung cancer	0.000187	0.000723	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000187	0.000722	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2A7—lung cancer	0.000185	0.000715	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SDC4—lung cancer	0.000181	0.0007	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000175	0.000679	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CKB—lung cancer	0.000174	0.000672	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Irinotecan—lung cancer	0.000173	0.000437	CcSEcCtD
Paricalcitol—VDR—Gene Expression—SKI—lung cancer	0.000172	0.000665	CbGpPWpGaD
Paricalcitol—Paraesthesia—Paclitaxel—lung cancer	0.000172	0.000434	CcSEcCtD
Paricalcitol—Hypertension—Docetaxel—lung cancer	0.000171	0.000434	CcSEcCtD
Paricalcitol—Dyspnoea—Paclitaxel—lung cancer	0.00017	0.000431	CcSEcCtD
Paricalcitol—Somnolence—Paclitaxel—lung cancer	0.00017	0.00043	CcSEcCtD
Paricalcitol—Decreased appetite—Etoposide—lung cancer	0.00017	0.000429	CcSEcCtD
Paricalcitol—Myalgia—Docetaxel—lung cancer	0.000169	0.000428	CcSEcCtD
Paricalcitol—Chest pain—Docetaxel—lung cancer	0.000169	0.000428	CcSEcCtD
Paricalcitol—Arthralgia—Docetaxel—lung cancer	0.000169	0.000428	CcSEcCtD
Paricalcitol—Nausea—Vinorelbine—lung cancer	0.000169	0.000427	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Etoposide—lung cancer	0.000168	0.000426	CcSEcCtD
Paricalcitol—Dyspepsia—Paclitaxel—lung cancer	0.000168	0.000426	CcSEcCtD
Paricalcitol—Body temperature increased—Cisplatin—lung cancer	0.000168	0.000426	CcSEcCtD
Paricalcitol—Asthenia—Irinotecan—lung cancer	0.000168	0.000426	CcSEcCtD
Paricalcitol—Fatigue—Etoposide—lung cancer	0.000168	0.000425	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000168	0.000425	CcSEcCtD
Paricalcitol—Constipation—Etoposide—lung cancer	0.000167	0.000422	CcSEcCtD
Paricalcitol—Pain—Etoposide—lung cancer	0.000167	0.000422	CcSEcCtD
Paricalcitol—Decreased appetite—Paclitaxel—lung cancer	0.000166	0.000421	CcSEcCtD
Paricalcitol—Dry mouth—Docetaxel—lung cancer	0.000165	0.000418	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000165	0.000418	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000165	0.000418	CcSEcCtD
Paricalcitol—Fatigue—Paclitaxel—lung cancer	0.000165	0.000417	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTA3—lung cancer	0.000165	0.000637	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—RRM1—lung cancer	0.000165	0.000637	CbGpPWpGaD
Paricalcitol—Asthenia—Gemcitabine—lung cancer	0.000164	0.000415	CcSEcCtD
Paricalcitol—Pain—Paclitaxel—lung cancer	0.000164	0.000414	CcSEcCtD
Paricalcitol—Constipation—Paclitaxel—lung cancer	0.000164	0.000414	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTM2—lung cancer	0.000163	0.000632	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CNDP2—lung cancer	0.000163	0.000632	CbGpPWpGaD
Paricalcitol—Confusional state—Docetaxel—lung cancer	0.000163	0.000413	CcSEcCtD
Paricalcitol—Pharyngitis—Methotrexate—lung cancer	0.000163	0.000413	CcSEcCtD
Paricalcitol—Urinary tract disorder—Methotrexate—lung cancer	0.000162	0.000411	CcSEcCtD
Paricalcitol—Oedema—Docetaxel—lung cancer	0.000162	0.00041	CcSEcCtD
Paricalcitol—Pruritus—Gemcitabine—lung cancer	0.000162	0.000409	CcSEcCtD
Paricalcitol—Urethral disorder—Methotrexate—lung cancer	0.000161	0.000408	CcSEcCtD
Paricalcitol—Infection—Docetaxel—lung cancer	0.000161	0.000407	CcSEcCtD
Paricalcitol—Weight decreased—Doxorubicin—lung cancer	0.000161	0.000407	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000161	0.000622	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Etoposide—lung cancer	0.000161	0.000407	CcSEcCtD
Paricalcitol—Diarrhoea—Irinotecan—lung cancer	0.00016	0.000406	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—EGFR—lung cancer	0.00016	0.000618	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.00016	0.000618	CbGpPWpGaD
Paricalcitol—Pneumonia—Doxorubicin—lung cancer	0.00016	0.000404	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Etoposide—lung cancer	0.000159	0.000404	CcSEcCtD
Paricalcitol—Shock—Docetaxel—lung cancer	0.000159	0.000403	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—MTMR3—lung cancer	0.000159	0.000615	CbGpPWpGaD
Paricalcitol—Nervous system disorder—Docetaxel—lung cancer	0.000159	0.000402	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000159	0.000614	CbGpPWpGaD
Paricalcitol—Infestation—Doxorubicin—lung cancer	0.000159	0.000401	CcSEcCtD
Paricalcitol—Infestation NOS—Doxorubicin—lung cancer	0.000159	0.000401	CcSEcCtD
Paricalcitol—Feeling abnormal—Paclitaxel—lung cancer	0.000158	0.000399	CcSEcCtD
Paricalcitol—Skin disorder—Docetaxel—lung cancer	0.000157	0.000398	CcSEcCtD
Paricalcitol—Hypersensitivity—Cisplatin—lung cancer	0.000157	0.000397	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Paclitaxel—lung cancer	0.000156	0.000396	CcSEcCtD
Paricalcitol—Diarrhoea—Gemcitabine—lung cancer	0.000156	0.000395	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000155	0.0006	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000155	0.0006	CbGpPWpGaD
Paricalcitol—Dizziness—Irinotecan—lung cancer	0.000155	0.000392	CcSEcCtD
Paricalcitol—Urticaria—Etoposide—lung cancer	0.000155	0.000392	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PGAM1—lung cancer	0.000155	0.000599	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—B4GALT5—lung cancer	0.000155	0.000599	CbGpPWpGaD
Paricalcitol—Anorexia—Docetaxel—lung cancer	0.000154	0.000391	CcSEcCtD
Paricalcitol—Body temperature increased—Etoposide—lung cancer	0.000154	0.00039	CcSEcCtD
Paricalcitol—Abdominal pain—Etoposide—lung cancer	0.000154	0.00039	CcSEcCtD
Paricalcitol—Urinary tract infection—Doxorubicin—lung cancer	0.000154	0.00039	CcSEcCtD
Paricalcitol—Conjunctivitis—Doxorubicin—lung cancer	0.000154	0.00039	CcSEcCtD
Paricalcitol—Eye disorder—Methotrexate—lung cancer	0.000154	0.000389	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000153	0.000593	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000153	0.000592	CbGpPWpGaD
Paricalcitol—Asthenia—Cisplatin—lung cancer	0.000153	0.000386	CcSEcCtD
Paricalcitol—Cardiac disorder—Methotrexate—lung cancer	0.000153	0.000386	CcSEcCtD
Paricalcitol—Sweating—Doxorubicin—lung cancer	0.000152	0.000385	CcSEcCtD
Paricalcitol—Urticaria—Paclitaxel—lung cancer	0.000152	0.000384	CcSEcCtD
Paricalcitol—Hypotension—Docetaxel—lung cancer	0.000151	0.000383	CcSEcCtD
Paricalcitol—Body temperature increased—Paclitaxel—lung cancer	0.000151	0.000382	CcSEcCtD
Paricalcitol—Abdominal pain—Paclitaxel—lung cancer	0.000151	0.000382	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTA4—lung cancer	0.000151	0.000583	CbGpPWpGaD
Paricalcitol—Epistaxis—Doxorubicin—lung cancer	0.00015	0.000378	CcSEcCtD
Paricalcitol—Angiopathy—Methotrexate—lung cancer	0.000149	0.000377	CcSEcCtD
Paricalcitol—Vomiting—Irinotecan—lung cancer	0.000149	0.000377	CcSEcCtD
Paricalcitol—Sinusitis—Doxorubicin—lung cancer	0.000149	0.000376	CcSEcCtD
Paricalcitol—Immune system disorder—Methotrexate—lung cancer	0.000149	0.000376	CcSEcCtD
Paricalcitol—Mediastinal disorder—Methotrexate—lung cancer	0.000148	0.000375	CcSEcCtD
Paricalcitol—Rash—Irinotecan—lung cancer	0.000148	0.000374	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYP2A7—lung cancer	0.000148	0.000572	CbGpPWpGaD
Paricalcitol—Dermatitis—Irinotecan—lung cancer	0.000148	0.000374	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000148	0.000374	CcSEcCtD
Paricalcitol—Chills—Methotrexate—lung cancer	0.000148	0.000373	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000147	0.00057	CbGpPWpGaD
Paricalcitol—Headache—Irinotecan—lung cancer	0.000147	0.000372	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTA2—lung cancer	0.000147	0.000568	CbGpPWpGaD
Paricalcitol—Insomnia—Docetaxel—lung cancer	0.000147	0.000371	CcSEcCtD
Paricalcitol—Diarrhoea—Cisplatin—lung cancer	0.000146	0.000369	CcSEcCtD
Paricalcitol—Paraesthesia—Docetaxel—lung cancer	0.000146	0.000368	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—lung cancer	0.000145	0.000368	CcSEcCtD
Paricalcitol—Vomiting—Gemcitabine—lung cancer	0.000145	0.000367	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SDC4—lung cancer	0.000145	0.000559	CbGpPWpGaD
Paricalcitol—Dyspnoea—Docetaxel—lung cancer	0.000144	0.000366	CcSEcCtD
Paricalcitol—Somnolence—Docetaxel—lung cancer	0.000144	0.000365	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—lung cancer	0.000144	0.000364	CcSEcCtD
Paricalcitol—Rash—Gemcitabine—lung cancer	0.000144	0.000364	CcSEcCtD
Paricalcitol—Dermatitis—Gemcitabine—lung cancer	0.000144	0.000364	CcSEcCtD
Paricalcitol—Hypersensitivity—Etoposide—lung cancer	0.000144	0.000364	CcSEcCtD
Paricalcitol—Malnutrition—Methotrexate—lung cancer	0.000143	0.000362	CcSEcCtD
Paricalcitol—Headache—Gemcitabine—lung cancer	0.000143	0.000362	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000143	0.000553	CbGpPWpGaD
Paricalcitol—Dyspepsia—Docetaxel—lung cancer	0.000143	0.000361	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTA1—lung cancer	0.000142	0.000548	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Doxorubicin—lung cancer	0.000142	0.000358	CcSEcCtD
Paricalcitol—Pharyngitis—Doxorubicin—lung cancer	0.000141	0.000358	CcSEcCtD
Paricalcitol—Decreased appetite—Docetaxel—lung cancer	0.000141	0.000356	CcSEcCtD
Paricalcitol—Hypersensitivity—Paclitaxel—lung cancer	0.000141	0.000356	CcSEcCtD
Paricalcitol—Urinary tract disorder—Doxorubicin—lung cancer	0.000141	0.000356	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.00014	0.000542	CbGpPWpGaD
Paricalcitol—Oedema peripheral—Doxorubicin—lung cancer	0.00014	0.000355	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—lung cancer	0.00014	0.000355	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ABCC3—lung cancer	0.00014	0.000542	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Docetaxel—lung cancer	0.00014	0.000354	CcSEcCtD
Paricalcitol—Asthenia—Etoposide—lung cancer	0.00014	0.000354	CcSEcCtD
Paricalcitol—Connective tissue disorder—Doxorubicin—lung cancer	0.00014	0.000354	CcSEcCtD
Paricalcitol—Fatigue—Docetaxel—lung cancer	0.00014	0.000354	CcSEcCtD
Paricalcitol—Urethral disorder—Doxorubicin—lung cancer	0.00014	0.000353	CcSEcCtD
Paricalcitol—Nausea—Irinotecan—lung cancer	0.000139	0.000352	CcSEcCtD
Paricalcitol—Constipation—Docetaxel—lung cancer	0.000139	0.000351	CcSEcCtD
Paricalcitol—Pain—Docetaxel—lung cancer	0.000139	0.000351	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—lung cancer	0.000138	0.00035	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000138	0.000535	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RARB—lung cancer	0.000138	0.000534	CbGpPWpGaD
Paricalcitol—Pruritus—Etoposide—lung cancer	0.000138	0.000349	CcSEcCtD
Paricalcitol—Asthenia—Paclitaxel—lung cancer	0.000137	0.000347	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—AKR1C1—lung cancer	0.000136	0.000525	CbGpPWpGaD
Paricalcitol—Nausea—Gemcitabine—lung cancer	0.000136	0.000343	CcSEcCtD
Paricalcitol—Vomiting—Cisplatin—lung cancer	0.000135	0.000342	CcSEcCtD
Paricalcitol—Pruritus—Paclitaxel—lung cancer	0.000135	0.000342	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NPPA—lung cancer	0.000135	0.00052	CbGpPWpGaD
Paricalcitol—Rash—Cisplatin—lung cancer	0.000134	0.00034	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—lung cancer	0.000134	0.000519	CbGpPWpGaD
Paricalcitol—Dermatitis—Cisplatin—lung cancer	0.000134	0.000339	CcSEcCtD
Paricalcitol—Feeling abnormal—Docetaxel—lung cancer	0.000134	0.000338	CcSEcCtD
Paricalcitol—Diarrhoea—Etoposide—lung cancer	0.000133	0.000338	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—lung cancer	0.000133	0.000337	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—lung cancer	0.000133	0.000336	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Docetaxel—lung cancer	0.000133	0.000335	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—lung cancer	0.000132	0.000335	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—lung cancer	0.000132	0.000334	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—RRM1—lung cancer	0.000132	0.000509	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTA3—lung cancer	0.000132	0.000509	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—UGT1A1—lung cancer	0.000132	0.000509	CbGpPWpGaD
Paricalcitol—Diarrhoea—Paclitaxel—lung cancer	0.000131	0.000331	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00013	0.000504	CbGpPWpGaD
Paricalcitol—Angiopathy—Doxorubicin—lung cancer	0.000129	0.000327	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—lung cancer	0.000129	0.000327	CcSEcCtD
Paricalcitol—Dizziness—Etoposide—lung cancer	0.000129	0.000326	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—lung cancer	0.000129	0.000325	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—lung cancer	0.000129	0.000325	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—lung cancer	0.000128	0.000325	CcSEcCtD
Paricalcitol—Abdominal pain—Docetaxel—lung cancer	0.000128	0.000324	CcSEcCtD
Paricalcitol—Body temperature increased—Docetaxel—lung cancer	0.000128	0.000324	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—lung cancer	0.000128	0.000324	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—lung cancer	0.000128	0.000323	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—lung cancer	0.000127	0.000322	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GNG11—lung cancer	0.000127	0.000491	CbGpPWpGaD
Paricalcitol—Dizziness—Paclitaxel—lung cancer	0.000126	0.00032	CcSEcCtD
Paricalcitol—Nausea—Cisplatin—lung cancer	0.000126	0.00032	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000126	0.000489	CbGpPWpGaD
Paricalcitol—Alopecia—Doxorubicin—lung cancer	0.000126	0.000318	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000125	0.000484	CbGpPWpGaD
Paricalcitol—Cough—Methotrexate—lung cancer	0.000125	0.000316	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—lung cancer	0.000125	0.000316	CcSEcCtD
Paricalcitol—Vomiting—Etoposide—lung cancer	0.000124	0.000314	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—lung cancer	0.000124	0.000314	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—B4GALT5—lung cancer	0.000124	0.000479	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000123	0.000477	CbGpPWpGaD
Paricalcitol—Rash—Etoposide—lung cancer	0.000123	0.000311	CcSEcCtD
Paricalcitol—Dermatitis—Etoposide—lung cancer	0.000123	0.000311	CcSEcCtD
Paricalcitol—Headache—Etoposide—lung cancer	0.000122	0.000309	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—lung cancer	0.000122	0.000308	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—lung cancer	0.000122	0.000308	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—lung cancer	0.000122	0.000308	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—lung cancer	0.000122	0.000308	CcSEcCtD
Paricalcitol—Vomiting—Paclitaxel—lung cancer	0.000122	0.000308	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—lung cancer	0.000121	0.000307	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000121	0.000306	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALDOA—lung cancer	0.000121	0.000468	CbGpPWpGaD
Paricalcitol—Rash—Paclitaxel—lung cancer	0.000121	0.000305	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTA4—lung cancer	0.00012	0.000466	CbGpPWpGaD
Paricalcitol—Dermatitis—Paclitaxel—lung cancer	0.00012	0.000305	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—lung cancer	0.00012	0.000305	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—lung cancer	0.00012	0.000305	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—lung cancer	0.00012	0.000303	CcSEcCtD
Paricalcitol—Headache—Paclitaxel—lung cancer	0.00012	0.000303	CcSEcCtD
Paricalcitol—Hypersensitivity—Docetaxel—lung cancer	0.000119	0.000302	CcSEcCtD
Paricalcitol—Muscle spasms—Doxorubicin—lung cancer	0.000119	0.000301	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—lung cancer	0.000118	0.000298	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTA2—lung cancer	0.000117	0.000454	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NCOA3—lung cancer	0.000117	0.000454	CbGpPWpGaD
Paricalcitol—Asthenia—Docetaxel—lung cancer	0.000116	0.000294	CcSEcCtD
Paricalcitol—Infection—Methotrexate—lung cancer	0.000116	0.000294	CcSEcCtD
Paricalcitol—Nausea—Etoposide—lung cancer	0.000116	0.000293	CcSEcCtD
Paricalcitol—VDR—Gene Expression—HSPB1—lung cancer	0.000116	0.000448	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000116	0.000447	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000115	0.000446	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Doxorubicin—lung cancer	0.000115	0.000291	CcSEcCtD
Paricalcitol—Pruritus—Docetaxel—lung cancer	0.000115	0.00029	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—lung cancer	0.000115	0.00029	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—lung cancer	0.000115	0.00029	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000114	0.000442	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCG2—lung cancer	0.000114	0.000442	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADCY1—lung cancer	0.000114	0.000442	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000114	0.000441	CbGpPWpGaD
Paricalcitol—Agitation—Doxorubicin—lung cancer	0.000114	0.000288	CcSEcCtD
Paricalcitol—Nausea—Paclitaxel—lung cancer	0.000114	0.000287	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—lung cancer	0.000113	0.000287	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTA1—lung cancer	0.000113	0.000438	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Methotrexate—lung cancer	0.000113	0.000286	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000113	0.000436	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HPGDS—lung cancer	0.000112	0.000433	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ENO2—lung cancer	0.000112	0.000433	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCC3—lung cancer	0.000112	0.000433	CbGpPWpGaD
Paricalcitol—Malaise—Doxorubicin—lung cancer	0.000112	0.000283	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000111	0.000431	CbGpPWpGaD
Paricalcitol—Vertigo—Doxorubicin—lung cancer	0.000111	0.000282	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—lung cancer	0.000111	0.000282	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PPP2R1B—lung cancer	0.000111	0.00043	CbGpPWpGaD
Paricalcitol—Syncope—Doxorubicin—lung cancer	0.000111	0.000281	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—lung cancer	0.000111	0.000281	CcSEcCtD
Paricalcitol—Diarrhoea—Docetaxel—lung cancer	0.000111	0.000281	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.00011	0.000425	CbGpPWpGaD
Paricalcitol—Palpitations—Doxorubicin—lung cancer	0.00011	0.000277	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—lung cancer	0.000109	0.000276	CcSEcCtD
Paricalcitol—Loss of consciousness—Doxorubicin—lung cancer	0.000109	0.000276	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTT1—lung cancer	0.000109	0.00042	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKR1C1—lung cancer	0.000108	0.000419	CbGpPWpGaD
Paricalcitol—Cough—Doxorubicin—lung cancer	0.000108	0.000274	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000108	0.000416	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GCLC—lung cancer	0.000107	0.000415	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2A6—lung cancer	0.000107	0.000415	CbGpPWpGaD
Paricalcitol—Dizziness—Docetaxel—lung cancer	0.000107	0.000271	CcSEcCtD
Paricalcitol—Hypertension—Doxorubicin—lung cancer	0.000107	0.000271	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000107	0.000414	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—CREBBP—lung cancer	0.000107	0.000412	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000106	0.000269	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—lung cancer	0.000106	0.000267	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—lung cancer	0.000106	0.000267	CcSEcCtD
Paricalcitol—Myalgia—Doxorubicin—lung cancer	0.000106	0.000267	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—lung cancer	0.000106	0.000267	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—UGT1A1—lung cancer	0.000105	0.000407	CbGpPWpGaD
Paricalcitol—Anxiety—Doxorubicin—lung cancer	0.000105	0.000266	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—lung cancer	0.000105	0.000265	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000105	0.000265	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—lung cancer	0.000104	0.000264	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—lung cancer	0.000104	0.000264	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—lung cancer	0.000104	0.000263	CcSEcCtD
Paricalcitol—Dry mouth—Doxorubicin—lung cancer	0.000103	0.000261	CcSEcCtD
Paricalcitol—Vomiting—Docetaxel—lung cancer	0.000103	0.000261	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—lung cancer	0.000103	0.00026	CcSEcCtD
Paricalcitol—Rash—Docetaxel—lung cancer	0.000102	0.000259	CcSEcCtD
Paricalcitol—Dermatitis—Docetaxel—lung cancer	0.000102	0.000258	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NOTCH3—lung cancer	0.000102	0.000394	CbGpPWpGaD
Paricalcitol—Confusional state—Doxorubicin—lung cancer	0.000102	0.000258	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ENO1—lung cancer	0.000102	0.000394	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000102	0.000393	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GNG11—lung cancer	0.000102	0.000393	CbGpPWpGaD
Paricalcitol—Decreased appetite—Methotrexate—lung cancer	0.000102	0.000257	CcSEcCtD
Paricalcitol—Headache—Docetaxel—lung cancer	0.000102	0.000257	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000101	0.000392	CbGpPWpGaD
Paricalcitol—Oedema—Doxorubicin—lung cancer	0.000101	0.000256	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—lung cancer	0.000101	0.000255	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—lung cancer	0.000101	0.000255	CcSEcCtD
Paricalcitol—Infection—Doxorubicin—lung cancer	0.0001	0.000254	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.0001	0.000387	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.0001	0.000387	CbGpPWpGaD
Paricalcitol—Pain—Methotrexate—lung cancer	9.99e-05	0.000253	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—lung cancer	9.95e-05	0.000252	CcSEcCtD
Paricalcitol—Nervous system disorder—Doxorubicin—lung cancer	9.92e-05	0.000251	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	9.86e-05	0.000381	CbGpPWpGaD
Paricalcitol—Skin disorder—Doxorubicin—lung cancer	9.82e-05	0.000249	CcSEcCtD
Paricalcitol—Hyperhidrosis—Doxorubicin—lung cancer	9.78e-05	0.000247	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ALDOA—lung cancer	9.67e-05	0.000374	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—JUNB—lung cancer	9.66e-05	0.000373	CbGpPWpGaD
Paricalcitol—Anorexia—Doxorubicin—lung cancer	9.64e-05	0.000244	CcSEcCtD
Paricalcitol—Nausea—Docetaxel—lung cancer	9.63e-05	0.000244	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—lung cancer	9.63e-05	0.000244	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—lung cancer	9.55e-05	0.000242	CcSEcCtD
Paricalcitol—Hypotension—Doxorubicin—lung cancer	9.45e-05	0.000239	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—NCOA3—lung cancer	9.39e-05	0.000363	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	9.37e-05	0.000362	CbGpPWpGaD
Paricalcitol—Urticaria—Methotrexate—lung cancer	9.28e-05	0.000235	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—lung cancer	9.23e-05	0.000234	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—lung cancer	9.23e-05	0.000234	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.22e-05	0.000233	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—lung cancer	9.15e-05	0.000231	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP2E1—lung cancer	9.13e-05	0.000353	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADCY1—lung cancer	9.13e-05	0.000353	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCG2—lung cancer	9.13e-05	0.000353	CbGpPWpGaD
Paricalcitol—Paraesthesia—Doxorubicin—lung cancer	9.08e-05	0.00023	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—NQO1—lung cancer	9.03e-05	0.000349	CbGpPWpGaD
Paricalcitol—Dyspnoea—Doxorubicin—lung cancer	9.02e-05	0.000228	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—lung cancer	8.99e-05	0.000228	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ENO2—lung cancer	8.95e-05	0.000346	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HPGDS—lung cancer	8.95e-05	0.000346	CbGpPWpGaD
Paricalcitol—Dyspepsia—Doxorubicin—lung cancer	8.9e-05	0.000225	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PPP2R1B—lung cancer	8.9e-05	0.000344	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.84e-05	0.000342	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	8.82e-05	0.000341	CbGpPWpGaD
Paricalcitol—Decreased appetite—Doxorubicin—lung cancer	8.79e-05	0.000222	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.76e-05	0.000339	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—lung cancer	8.73e-05	0.000221	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—lung cancer	8.72e-05	0.000221	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTT1—lung cancer	8.69e-05	0.000336	CbGpPWpGaD
Paricalcitol—Constipation—Doxorubicin—lung cancer	8.65e-05	0.000219	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—lung cancer	8.65e-05	0.000219	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	8.62e-05	0.000333	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Methotrexate—lung cancer	8.61e-05	0.000218	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GCLC—lung cancer	8.58e-05	0.000332	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2A6—lung cancer	8.58e-05	0.000332	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—HPGDS—lung cancer	8.5e-05	0.000329	CbGpPWpGaD
Paricalcitol—Asthenia—Methotrexate—lung cancer	8.38e-05	0.000212	CcSEcCtD
Paricalcitol—Feeling abnormal—Doxorubicin—lung cancer	8.34e-05	0.000211	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Doxorubicin—lung cancer	8.27e-05	0.000209	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—lung cancer	8.26e-05	0.000209	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—lung cancer	8.24e-05	0.000319	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GCLC—lung cancer	8.15e-05	0.000315	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2A6—lung cancer	8.15e-05	0.000315	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—STK11—lung cancer	8.14e-05	0.000315	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ENO1—lung cancer	8.14e-05	0.000315	CbGpPWpGaD
Paricalcitol—Urticaria—Doxorubicin—lung cancer	8.04e-05	0.000203	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—lung cancer	8e-05	0.000202	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—lung cancer	8e-05	0.000202	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—lung cancer	7.99e-05	0.000202	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—lung cancer	7.72e-05	0.000195	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.64e-05	0.000295	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTP1—lung cancer	7.53e-05	0.000291	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Doxorubicin—lung cancer	7.45e-05	0.000189	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—lung cancer	7.43e-05	0.000188	CcSEcCtD
Paricalcitol—Rash—Methotrexate—lung cancer	7.37e-05	0.000186	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—lung cancer	7.36e-05	0.000186	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CAT—lung cancer	7.33e-05	0.000283	CbGpPWpGaD
Paricalcitol—Headache—Methotrexate—lung cancer	7.32e-05	0.000185	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYP2E1—lung cancer	7.3e-05	0.000282	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.29e-05	0.000282	CbGpPWpGaD
Paricalcitol—Asthenia—Doxorubicin—lung cancer	7.26e-05	0.000184	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—NQO1—lung cancer	7.22e-05	0.000279	CbGpPWpGaD
Paricalcitol—Pruritus—Doxorubicin—lung cancer	7.16e-05	0.000181	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ABCB1—lung cancer	7.13e-05	0.000276	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ERCC2—lung cancer	7.01e-05	0.000271	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TYMS—lung cancer	7e-05	0.000271	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	6.99e-05	0.00027	CbGpPWpGaD
Paricalcitol—Nausea—Methotrexate—lung cancer	6.94e-05	0.000176	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—CYP2E1—lung cancer	6.93e-05	0.000268	CbGpPWpGaD
Paricalcitol—Diarrhoea—Doxorubicin—lung cancer	6.92e-05	0.000175	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTM1—lung cancer	6.92e-05	0.000268	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	6.83e-05	0.000264	CbGpPWpGaD
Paricalcitol—Dizziness—Doxorubicin—lung cancer	6.69e-05	0.000169	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP1A1—lung cancer	6.56e-05	0.000254	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ERCC2—lung cancer	6.51e-05	0.000252	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—STK11—lung cancer	6.51e-05	0.000252	CbGpPWpGaD
Paricalcitol—Vomiting—Doxorubicin—lung cancer	6.43e-05	0.000163	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—lung cancer	6.38e-05	0.000161	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—lung cancer	6.37e-05	0.000161	CcSEcCtD
Paricalcitol—Headache—Doxorubicin—lung cancer	6.34e-05	0.00016	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—MYC—lung cancer	6.33e-05	0.000245	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTP1—lung cancer	6.02e-05	0.000233	CbGpPWpGaD
Paricalcitol—Nausea—Doxorubicin—lung cancer	6.01e-05	0.000152	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CAT—lung cancer	5.86e-05	0.000227	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—lung cancer	5.71e-05	0.000221	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCB1—lung cancer	5.7e-05	0.00022	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	5.64e-05	0.000218	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA1—lung cancer	5.63e-05	0.000218	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TYMS—lung cancer	5.6e-05	0.000216	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—lung cancer	5.53e-05	0.000214	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.39e-05	0.000208	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.25e-05	0.000203	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1A1—lung cancer	5.24e-05	0.000203	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ERCC2—lung cancer	5.2e-05	0.000201	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.18e-05	0.0002	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CG—lung cancer	5.14e-05	0.000199	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CREBBP—lung cancer	5.13e-05	0.000199	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.98e-05	0.000192	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.91e-05	0.00019	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—POMC—lung cancer	4.89e-05	0.000189	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CREBBP—lung cancer	4.76e-05	0.000184	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CD—lung cancer	4.52e-05	0.000175	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA1—lung cancer	4.5e-05	0.000174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—lung cancer	4.46e-05	0.000172	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AZIN2—lung cancer	4.38e-05	0.000169	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.38e-05	0.000169	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CG—lung cancer	4.11e-05	0.000159	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CB—lung cancer	3.94e-05	0.000152	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—POMC—lung cancer	3.91e-05	0.000151	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—lung cancer	3.9e-05	0.000151	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CREBBP—lung cancer	3.81e-05	0.000147	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ATP5H—lung cancer	3.72e-05	0.000144	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—POMC—lung cancer	3.71e-05	0.000144	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CD—lung cancer	3.61e-05	0.00014	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—lung cancer	3.56e-05	0.000138	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTEN—lung cancer	3.4e-05	0.000132	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLBD1—lung cancer	3.32e-05	0.000128	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—EP300—lung cancer	3.24e-05	0.000125	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CB—lung cancer	3.15e-05	0.000122	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MAPK3—lung cancer	3.13e-05	0.000121	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—lung cancer	3.12e-05	0.000121	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MYC—lung cancer	3.05e-05	0.000118	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD17B10—lung cancer	3.04e-05	0.000117	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CKB—lung cancer	2.82e-05	0.000109	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTEN—lung cancer	2.72e-05	0.000105	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CNDP2—lung cancer	2.65e-05	0.000103	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM2—lung cancer	2.65e-05	0.000103	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—EP300—lung cancer	2.59e-05	0.0001	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTMR3—lung cancer	2.58e-05	9.98e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PGAM1—lung cancer	2.51e-05	9.72e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CA—lung cancer	2.4e-05	9.28e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2A7—lung cancer	2.4e-05	9.28e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SDC4—lung cancer	2.35e-05	9.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—RRM1—lung cancer	2.14e-05	8.27e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA3—lung cancer	2.14e-05	8.27e-05	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—lung cancer	2.11e-05	8.17e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—B4GALT5—lung cancer	2.01e-05	7.77e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—lung cancer	1.96e-05	7.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA4—lung cancer	1.96e-05	7.56e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CA—lung cancer	1.92e-05	7.42e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA2—lung cancer	1.91e-05	7.37e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA1—lung cancer	1.84e-05	7.11e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCC3—lung cancer	1.82e-05	7.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKR1C1—lung cancer	1.76e-05	6.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UGT1A1—lung cancer	1.71e-05	6.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GNG11—lung cancer	1.65e-05	6.37e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDOA—lung cancer	1.57e-05	6.07e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—lung cancer	1.57e-05	6.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOA3—lung cancer	1.52e-05	5.89e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADCY1—lung cancer	1.48e-05	5.73e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG2—lung cancer	1.48e-05	5.73e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HPGDS—lung cancer	1.45e-05	5.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO2—lung cancer	1.45e-05	5.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.44e-05	5.59e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—lung cancer	1.41e-05	5.45e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCLC—lung cancer	1.39e-05	5.39e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2A6—lung cancer	1.39e-05	5.39e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO1—lung cancer	1.32e-05	5.11e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2E1—lung cancer	1.18e-05	4.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NQO1—lung cancer	1.17e-05	4.53e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—STK11—lung cancer	1.06e-05	4.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—lung cancer	9.77e-06	3.78e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAT—lung cancer	9.51e-06	3.68e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCB1—lung cancer	9.25e-06	3.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TYMS—lung cancer	9.08e-06	3.51e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—lung cancer	8.98e-06	3.47e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1A1—lung cancer	8.51e-06	3.29e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ERCC2—lung cancer	8.44e-06	3.26e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA1—lung cancer	7.3e-06	2.82e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CG—lung cancer	6.67e-06	2.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—POMC—lung cancer	6.35e-06	2.45e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CREBBP—lung cancer	6.18e-06	2.39e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CD—lung cancer	5.86e-06	2.27e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—lung cancer	5.79e-06	2.24e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CB—lung cancer	5.11e-06	1.98e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—lung cancer	5.06e-06	1.96e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTEN—lung cancer	4.42e-06	1.71e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—EP300—lung cancer	4.21e-06	1.63e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CA—lung cancer	3.11e-06	1.2e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—lung cancer	2.54e-06	9.84e-06	CbGpPWpGaD
